[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heart-rhythm-disorders\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heart-rhythm-disorders":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,56,94],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":33,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":4},"100623450","screening-for-cardiac-and-cardiac-associated-pathology-using-single-channel-electrocardiogram-100623450",false,"NCT07396792","Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram","Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram Analyzed With Machine Learning Models","Inclusion Criteria:\n\n1. The presence of written informed consent of the patient to participate in the study\n2. Availability of examination data allowing for the verification or exclusion of cardiac and cardiac-associated pathology\n3. Age 18 years old and older\n\nNon-inclusion criteria:\n\n1. Patients with an implanted permanent pacemaker;\n2. ECG changes that prevent spectral analysis;\n3. Conditions that may impair the quality of the ECG recording (Parkinson's disease, essential tremor, etc.);\n4. Conditions that make ECG recording in lead I impossible (congenital anomalies of the upper limbs, traumatic amputation of the upper limbs).\n5. Lack of written informed consent from the patient to participate in the study.\n\nExclusion Criteria:\n\n1. Poor quality of the ECG recording on a single-channel ECG monitor\n2. Insufficient examination data to verify or exclude cardiac or cardiac-associated pathology;\n3. Patient's unwillingness to continue participating in the study for any reason.",true,"ALL","18 Years",{"count":20,"type":21},4000,"ESTIMATED","OBSERVATIONAL","It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 4000 patients 18 years old and older in the training sample and 1000 patients over 18 years old in the test sample (the total number of patients is at least 5000 people). Patients will be included in the study if they have undergone a full examination (laboratory, clinical and instrumental), allowing for the verification or exclusion of cardiac and cardiac-associated pathology in accordance with current recommendations. During the course of the study, the authors of the work do not interfere with the above-mentioned scope of the examination, which is carried out on patients in accordance with clinical guidelines. All patients included in the study will undergo ECG recording in standard lead I for 1 minute twice, followed by spectral analysis of the obtained data, which will be stored at the remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform. The result of this study will be the identification of ECG parameters that will correlate with cardiac and cardiac-associated pathology",[25,26,27,28,29,30,31,32],"Arterial Hypertension","Heart Rhythm Disorders","Valvular Heart Diseases","Heart Failure","Diabetes Mellitus","Chronic Kidney Disease (Stage 3-4)","Metabolic Syndrome","Coronary Artery Disease",[34,35,36,37,38,39,40,41,42,43],"Screening","Electrocardiogramm","single-channel electrocardiogram","machine learning models","Coronary artery disease","diabetes mellitus","metabolic syndrome","anemia","hypercholesterolemia","arterial hypertension","NOT_YET_RECRUITING","2026-04-13",{"date":47,"type":48},"2026-04-16","ACTUAL",{"date":50,"type":21},"2026-04-01",{"date":52,"type":21},"2028-05-13",{"name":54,"class":55},"I.M. Sechenov First Moscow State Medical University","OTHER",{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":64,"targetDuration":4,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":93},"100620186","optimal-settings-for-anti-tachycardia-pacing-atp-on-icd-100620186","NCT07354347","Optimal Settings for Anti Tachycardia Pacing (ATP) on ICD","Optimal ATP Settings in the VT Zone for New Implantable Cardioverter Defibrillator (ICD) Implantation (DAN-ATP)","DAN-ATP","Inclusion Criteria:\n\n\\- ICD implantation for primary or secondary prophylactic indication\n\nExclusion Criteria:\n\n* None\n* Patients can actively opt out of participation in the study",{"count":65,"type":21},3980,"INTERVENTIONAL",[68],"NA","This is a pragmatic, two-group, cluster randomized trial designed to compare strategies for the Anti Tachycardia Pacing (ATP)-setting in the ventricular tachyarrhythmias (VT) zone when implanting a new implantable cardioverter defibrillator (ICD) in patients with heart disease in hospitals in Denmark.\n\nThe strategies are: \"Burst\" or \"Ramp\" after 1. ATP (which is always burst) in VT zone. VT zone is defined between 180-249 (up to 269 in special cases) heartbeats per minute.\n\nThe ICD will give either:\n\nBurst: The ICD is programmed to give ATP with 4 bursts. Or Ramp: The ICD is programmed to give ATP with 1 burst and 3 ramps.\n\nThe participating hospitals will be assigned to one of two intervention strategies for periods of 4-months. The given intervention will follow the patient\u002FICD throughout the life time of the ICD, but with the possibility to reprogram at any time (intention to treat).\n\nIt is calculated that the study needs a total of 398 events (second to fourth ATP), which is estimated to require 3980 implanted ICDs. The participants will be followed until the end of the ICD life, which is estimated to be around 10 years.",[71,72,26,73],"Heart Disease","Implantable Cardioverter Defibrillator (ICD)","Ventricular Tachyarrhythmias",[75,76,77,78,79,80,81,82,83],"Heart failure","ICD","ATP","Anti Takykardi Pacing","Implantable Cardioverter Defibrillator","cluster randomisation","heart rhythm disorder","ventricular tachyarrhythmias","VT","2026-01-26",{"date":86,"type":48},"2026-01-27",{"date":88,"type":21},"2026-02-01",{"date":90,"type":21},"2041-07-31",{"name":92,"class":55},"Rigshospitalet, Denmark",1,{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":102,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":104,"conditions":105,"keywords":118,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":132},"100358354","the-role-of-concomitant-diseases-in-postoperative-complications-risk-stratification-100358354","NCT03945968","The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.","The Role of Concomitant Diseases in Postoperative Complications Risk Stratification - a Prospective Observational Multi-center Cohort Study","STOPRISK","Inclusion Criteria:\n\n* surgical interventions on the abdominal organs,\n* 1-3 ASA physical status class\n\nExclusion Criteria:\n\n* the inability to assess the factors included in the study,\n* acute massive blood loss, aspiration,\n* bronchospasm,\n* anaphylactic reactions,\n* malignant hyperthermia",{"count":103,"type":21},16000,"Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.",[106,107,108,109,110,111,26,112,113,114,115,116,117],"Coronary Heart Disease","Anemia","Bronchial Asthma","Stroke","Epilepsy","Parkinson's Disease","Alzheimer's Disease","Neuromuscular Diseases","Diabetes","Chronic Heart Failure","Chronic Obstructive Pulmonary Disease","Chronic Kidney Diseases",[119,120,121],"anesthesia","concomitant diseases","risk stratification","RECRUITING","2025-04-01",{"date":125,"type":48},"2025-04-04",{"date":127,"type":48},"2019-07-01",{"date":129,"type":21},"2026-02-28",{"name":131,"class":55},"Russian Federation of Anesthesiologists and Reanimatologists",38]